Welcome to our H2 regulation and policy update for the biotech industry and the life science research sector. Under the new authorization, this program will run for the next 3 years, sundowning on the 30th of September 2029. Biotech and pharma companies receiving federal contracts, grants or loans are not permitted to use the technology or services of any companies with this label. Furthermore, allowing the government to retroactively cancel active research grants based on shifting, arbitrary definitions of ‘national interest’ introduces a massive risk to our scientific community. Sequencing superstars share their secrets for successful commercializationBiotech industry leaders reveal intriguing insights into the European biotech landscape and offer sage advice for anyone working in, or looking to establish, a biotech start-up.